Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5084766016 | Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5084767013 | Aluminium hydroxide and magnesium hydroxide and oxetacaine only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5084768015 | Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | est un(e) (attribut) | Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | true | Inferred relationship | Some | ||
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | Plays role | Laxative therapeutic role | true | Inferred relationship | Some | ||
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | a pour principe actif (attribut) | Oxethazaine | true | Inferred relationship | Some | 1 | |
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | a pour principe actif (attribut) | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 2 | |
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | est un(e) (attribut) | Product containing only aluminium hydroxide and magnesium hydroxide and oxetacaine (medicinal product) | true | Inferred relationship | Some | ||
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | a pour principe actif (attribut) | Aluminium hydroxide (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely aluminium hydroxide 58.2 milligram/milliliter and magnesium hydroxide 19.6 milligram/milliliter and oxetacaine 2 milligram/1 milliliter conventional release oral suspension (clinical drug) | est un(e) (attribut) | True | Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR